NCT01113242

Brief Summary

Cognitive disorders in Parkinson's disease (PD) are not as obvious as cognitive disorders in Alzheimer disease and their diagnosis tends to be delayed. If neuropsychological assessment of cognitive decline in Parkinson's disease is well established, the thresholds of cognitive testing corresponding to a dementia are unknown. Recently, new diagnosis criteria of dementia associated with PD have been proposed by the movement disorder society. In this study two groups of patients with idiopathic PD will be separated and compared according to their Mini Mental State Examination (MMSE) score (upper or lower than 26). Included patients will have clinically idiopathic PD, will be over 65 years old and will present cognitive complain. Cognitive and mood disorders as well as motor symptoms will be assessed using validated scales and a neuropsychological assessment dispatched in two visits will be performed . Differences in the distribution of data from the two groups of patients will be assessed in statistically analysis with non parametric tests. The purpose of this study is to determine the most effective tests and their threshold value corresponding to a pathological cognitive decline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 29, 2010

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2010

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

February 5, 2020

Status Verified

November 1, 2010

Enrollment Period

2.2 years

First QC Date

April 27, 2010

Last Update Submit

January 30, 2020

Conditions

Keywords

Parkinson Disease DementiaObservationalCase controlNeuropsychological assessment

Study Arms (2)

A:

Patients with idiopathic PD and with MMSE \< à 26

Other: Neuropsychological Assessment

B:

Patients with idiopathic PD and with MMSE ≥ à 26

Other: Neuropsychological Assessment

Interventions

Included patients had clinically idiopathic PD, were over 65 years old and presented with a cognitive complain. A detailed registration of clinical history (including review of motor, cognitive, and neuropsychiatric symptoms, comorbid medical conditions, and medications) and neurologic examination was performed. Exclusion criteria included other conditions than PD that could contribute substantially to the subject's motor and/or cognitive impairment, including neurologic and major psychiatric disorders ( delirium,…) affecting the cognitive functions. Patients with major cognitive impairment (i.e. Mental State Examination (MMSE) \<16/30) were also excluded.). Neuropsychological assessment explores working memory, episodic memory ,verbal fluency, executive functions and visuo constructive functions.

A:B:

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with idiopathic PD are issued from an ambulatory following at the department of Geriatrics

You may qualify if:

  • MMSE ≥ 16
  • impact of cognitive disorders in daily living
  • criteria of the UKPDSBB for PD
  • steady state in PD
  • benign delusions or treated psychosis are tolerated
  • informed consent obtained

You may not qualify if:

  • dementia from other origin than PD
  • cognitive decline without impact on daily living
  • MMSE \< 16
  • delirium in the last 3 months
  • Severe Depression
  • Central Anticholinergic medication
  • inability to perform the cognitive testing
  • major cerebrovascular disease
  • inability to give an informed consent (patients with protective measures)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Gériatrie, Hôpital de la Robertsau, Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Interventions

Neuropsychological Tests

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Michèle Kiesmann, MD

    University Hospital, Strasbourg, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2010

First Posted

April 29, 2010

Study Start

June 1, 2010

Primary Completion

August 1, 2012

Study Completion

September 1, 2012

Last Updated

February 5, 2020

Record last verified: 2010-11

Locations